These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 16877973

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
    MMW Fortschr Med; 2007 Nov 15; 149(46):52-3. PubMed ID: 18069195
    [No Abstract] [Full Text] [Related]

  • 3. Valsartan. Just a second-line antihypertensive drug.
    Can Fam Physician; 1999 Nov 15; 45():2626-8, 2630-3. PubMed ID: 10587770
    [Abstract] [Full Text] [Related]

  • 4. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
    MMW Fortschr Med; 2003 Dec 04; 145(49):18-9. PubMed ID: 14963986
    [No Abstract] [Full Text] [Related]

  • 5. Exforge HCT.
    Med Lett Drugs Ther; 2009 Jun 15; 51(1314):47. PubMed ID: 19528888
    [No Abstract] [Full Text] [Related]

  • 6. [Dilemma of antihypertensive therapy: high blood pressure diminishes, potency sometimes, too].
    MMW Fortschr Med; 2006 Sep 21; 148(38):17. PubMed ID: 17036956
    [No Abstract] [Full Text] [Related]

  • 7. Angiotensin receptor blockers and myocardial infarction.
    Verma S, Strauss M.
    BMJ; 2004 Nov 27; 329(7477):1248-9. PubMed ID: 15564232
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [First fixed combination of sartan and high-dosage diuretic. A strong duo against high blood pressure].
    MMW Fortschr Med; 2004 Apr 01; 146(14):45. PubMed ID: 15344757
    [No Abstract] [Full Text] [Related]

  • 10. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
    He YL, Ligueros-Saylan M, Sunkara G, Sabo R, Zhao C, Wang Y, Campestrini J, Pommier F, Dole K, Marion A, Dole WP, Howard D.
    J Clin Pharmacol; 2008 Jan 01; 48(1):85-95. PubMed ID: 17986525
    [Abstract] [Full Text] [Related]

  • 11. [Pharmocological therapeutics for chronic heart failure--how to use ARB (angiotensin receptor blocker].
    Kudo Y, Komuro I, Akazawa H.
    Nihon Rinsho; 2007 May 28; 65 Suppl 5():84-9. PubMed ID: 17571370
    [No Abstract] [Full Text] [Related]

  • 12. [Scientific evidence--applied in routine general practice. Successful decrease in pressure and risk].
    MMW Fortschr Med; 2006 May 04; 148(18):42-3. PubMed ID: 16736689
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Angiotensin-II-receptor inhibitors in pregnancy.
    Chung NA, Lip GY, Beevers M, Beevers DG.
    Lancet; 2001 May 19; 357(9268):1620-1. PubMed ID: 11386316
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aliskiren/valsartan (Valturna) for hypertension.
    Med Lett Drugs Ther; 2009 Nov 30; 51(1326):94-5. PubMed ID: 20224524
    [No Abstract] [Full Text] [Related]

  • 18. Angiotensin receptor blockers: dose does matter.
    Sarzani R, Dessì-Fulgheri P, Rappelli A.
    J Hypertens; 2008 Mar 30; 26(3):607-8; author reply 608. PubMed ID: 18300874
    [No Abstract] [Full Text] [Related]

  • 19. [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?].
    Zidek W.
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):41. PubMed ID: 15526662
    [No Abstract] [Full Text] [Related]

  • 20. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
    Roger N, Popovic I, Madelenat P, Mahieu-Caputo D.
    Gynecol Obstet Fertil; 2007 Jun 08; 35(6):556-60. PubMed ID: 17544313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.